Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2004 1
2005 1
2006 6
2007 7
2008 4
2009 4
2010 6
2011 8
2012 11
2013 14
2014 10
2015 10
2016 16
2017 14
2018 17
2019 16
2020 16
2021 28
2022 34
2023 22
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.
Ploussard G, Fiard G, Barret E, Brureau L, Créhange G, Dariane C, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Rozet F, Ruffion A, Sargos P, Beauval JB, Rouprêt M. Ploussard G, et al. Among authors: crehange g. Prog Urol. 2022 Nov;32(15):1275-1372. doi: 10.1016/j.purol.2022.07.148. Prog Urol. 2022. PMID: 36400483 Review.
Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy.
Robin S, Jolicoeur M, Palumbo S, Zilli T, Crehange G, De Hertogh O, Derashodian T, Sargos P, Salembier C, Supiot S, Udrescu C, Chapet O. Robin S, et al. Among authors: crehange g. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1243-1253. doi: 10.1016/j.ijrobp.2020.11.010. Epub 2020 Nov 10. Int J Radiat Oncol Biol Phys. 2021. PMID: 33186618
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus.
Zilli T, Achard V, Dal Pra A, Schmidt-Hegemann N, Jereczek-Fossa BA, Lancia A, Ingrosso G, Alongi F, Aluwini S, Arcangeli S, Blanchard P, Conde Moreno A, Couñago F, Créhange G, Dirix P, Gomez Iturriaga A, Guckenberger M, Pasquier D, Sargos P, Scorsetti M, Supiot S, Tree AC, Zapatero A, Le Guevelou J, Ost P, Belka C. Zilli T, et al. Among authors: crehange g. Radiother Oncol. 2022 Nov;176:199-207. doi: 10.1016/j.radonc.2022.10.005. Epub 2022 Oct 10. Radiother Oncol. 2022. PMID: 36228761 Free article.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Conroy T, Galais MP, Raoul JL, Bouché O, Gourgou-Bourgade S, Douillard JY, Etienne PL, Boige V, Martel-Lafay I, Michel P, Llacer-Moscardo C, François E, Créhange G, Abdelghani MB, Juzyna B, Bedenne L, Adenis A; Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group. Conroy T, et al. Among authors: crehange g. Lancet Oncol. 2014 Mar;15(3):305-14. doi: 10.1016/S1470-2045(14)70028-2. Epub 2014 Feb 18. Lancet Oncol. 2014. PMID: 24556041 Clinical Trial.
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A. Supiot S, et al. Among authors: crehange g. Eur Urol. 2021 Oct;80(4):405-414. doi: 10.1016/j.eururo.2021.06.010. Epub 2021 Jul 8. Eur Urol. 2021. PMID: 34247896 Clinical Trial.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S. Carrie C, et al. Among authors: crehange g. Lancet Oncol. 2019 Dec;20(12):1740-1749. doi: 10.1016/S1470-2045(19)30486-3. Epub 2019 Oct 16. Lancet Oncol. 2019. PMID: 31629656 Clinical Trial.
Specificities of clinical research in radiotherapy.
Hennequin C, Azria D, Blanchard P, Créhange G, Deutsch É, Lisbona A, Moyal É, Pasquier D, Roca L, Supiot S, Giraud P. Hennequin C, et al. Among authors: crehange g. Cancer Radiother. 2022 Feb-Apr;26(1-2):104-107. doi: 10.1016/j.canrad.2021.11.011. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34953712 Review.
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
Le Guevelou J, Sargos P, Ferretti L, Supiot S, Pasquier D, Créhange G, Blanchard P, Hennequin C, Chapet O, Schick U, Baty M, Masson I, Ploussard G, De Crevoisier R, Latorzeff I. Le Guevelou J, et al. Among authors: crehange g. Eur Urol Oncol. 2023 Aug 26:S2588-9311(23)00163-3. doi: 10.1016/j.euo.2023.08.003. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37640583 Review.
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Baboudjian M, Rajwa P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G; Prostate Cancer Committee of the Association Française d'Urologie CC-AFU. Baboudjian M, et al. Among authors: crehange g. Eur Urol Open Sci. 2022 May 19;41:35-44. doi: 10.1016/j.euros.2022.04.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35633829 Free PMC article. Review.
External radiotherapy for prostatic cancers.
de Crevoisier R, Supiot S, Créhange G, Pommier P, Latorzeff I, Chapet O, Pasquier D, Blanchard P, Schick U, Marchesi V, Sargos P, Hennequin C. de Crevoisier R, et al. Among authors: crehange g. Cancer Radiother. 2022 Feb-Apr;26(1-2):329-343. doi: 10.1016/j.canrad.2021.11.017. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34955419
222 results